METACLIPSE THERAPEUTICS CORP — Department of Health and Human Services SBIR: SBIR CONCEPT AWARD FOR DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATME
METACLIPSE THERAPEUTICS CORP — SBIR award from Department of Health and Human Services.
SBIR award competitive context
- Public SBIR obligation from Department of Health and Human Services to METACLIPSE THERAPEUTICS CORP. Use agency + tech-domain links below to map the broader competitive field.
- Obligated amount $299,984. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
MetaEclipse Therapeutics Corp received nearly $300,000 from NIH for an SBIR concept award to develop therapies or prevention methods targeting pediatric and rare cancers.
- Amount
- $299,984
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR
- NAICS
- 541713 · RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY
- Place of performance
- GA
- Period
- 2025-09-05 → 2026-09-04
Technology domains
Description
SBIR CONCEPT AWARD FOR DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS